Zur Rose AG (ISIN: CH0042615283) – Loss making failed IPO or long term growth opportunity ? | value and opportunity
ACXIT Capital Partners advises medpex on the trade sale of its e-commerce activities to Zur Rose Group - ACXIT Capital Partners
Investor Relations | Schindler Group
Zur Rose Aerzte AG Share Price CHF5.75
Downloads - Annual Report 2018 | Zur Rose Group AG
Zur Rose Group (SWX:ROSE) - Share price, News & Analysis - Simply Wall St
Olaf Heinrich, Head Germany, verlässt die Zur Rose-Gruppe; sein Nachfolger wird Walter Hess, Head Switzerland
ZUR ROSE GROUP AG : Shareholders Board Members Managers and Company Profile | CH0042615283 | MarketScreener
Zur Rose Group AG - Crunchbase Company Profile & Funding
Zur Rose Ecosystem - Annual Report 2018 | Zur Rose Group AG
Financial News | Beiersdorf
Christoph Herrmann – Head of Investor Relations – Zur Rose Group | LinkedIn
Zur Rose - News und Aktienkurs | Finanz und Wirtschaft
Corporate Governance - Annual Report 2020 | Zur Rose Group AG
Zur Rose Group - Pharmaceuticals - Overview, Competitors, and Employees | Apollo.io
Zur Rose AG (ISIN: CH0042615283) – Loss making failed IPO or long term growth opportunity ? | value and opportunity
ZUR ROSE GROUP AG : Shareholders Board Members Managers and Company Profile | CH0042615283 | MarketScreener
Zur Rose Group AG
Financials - Annual Report 2020 | Zur Rose Group AG
Our 2020 in review | UBS Global
Christoph Herrmann - Director Investor Relations - Zur Rose Group AG | XING
Financials - Annual Report 2020 | Zur Rose Group AG
EQS-News: Zur Rose Group AG: Aktionäre stimmen allen Anträgen zu
Corporate Governance - Annual Report 2020 | Zur Rose Group AG
